Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Restructuring Costs (2024 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Restructuring Costs for 2 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Restructuring Costs rose 766.67% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.5 million for FY2025, 55.73% down from the prior year.
  • Restructuring Costs hit $1.5 million in Q4 2025 for Bolt Biotherapeutics, up from -$222000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $3.6 million in Q2 2024 to a low of -$222000.0 in Q4 2024.